S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Vertex PharmaceuticalsBayer AktiengesellschaftRegeneron PharmaceuticalsTakeda PharmaceuticalZoetis
SymbolNASDAQ:VRTXOTCMKTS:BAYRYNASDAQ:REGNNYSE:TAKNYSE:ZTS
Price Information
Current Price$212.55$15.30$450.57$16.71$155.24
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score2.41.02.62.02.1
Analysis Score4.40.04.43.51.3
Community Score3.22.32.62.13.2
Dividend Score0.02.50.03.31.7
Ownership Score1.70.01.70.03.3
Earnings & Valuation Score2.50.04.41.31.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$291.85N/A$625.81$30.00$167.25
% Upside from Price Target37.31% upsideN/A38.89% upside79.53% upside7.74% upside
Trade Information
Market Cap$55.25 billion$57.07 billion$48.27 billion$52.68 billion$73.76 billion
Beta0.791.340.31.010.71
Average Volume2,206,589559,4981,112,4904,620,6331,942,984
Sales & Book Value
Annual Revenue$4.16 billion$48.23 billion$7.86 billion$30.20 billion$6.26 billion
Price / Sales13.271.186.141.7411.78
Cashflow$4.59 per share$3.36 per share$21.31 per share$3.20 per share$4.41 per share
Price / Cash46.274.5521.145.2335.17
Book Value$23.66 per share$14.27 per share$100.56 per share$13.80 per share$5.69 per share
Price / Book8.981.074.481.2127.28
Profitability
Net Income$1.18 billion$4.58 billion$2.12 billion$407.02 million$1.50 billion
EPS$4.29$1.77$21.47$1.78$3.64
Trailing P/E Ratio26.84N/A16.4755.7046.07
Forward P/E Ratio22.887.9713.297.6337.68
P/E Growth1.256.100.82N/A4.35
Net Margins38.51%-22.32%38.28%3.04%25.50%
Return on Equity (ROE)28.55%14.23%28.97%13.46%63.89%
Return on Assets (ROA)20.68%5.01%20.11%5.02%14.99%
Dividend
Annual PayoutN/A$0.53N/A$0.72$1.00
Dividend YieldN/A3.46%N/A4.31%0.64%
Three-Year Dividend GrowthN/AN/AN/A6.41%N/A
Payout RatioN/A29.94%N/A40.45%27.47%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A1 Years
Debt
Debt-to-Equity Ratio0.07%1.12%0.27%0.99%2.41%
Current Ratio3.72%1.10%3.89%1.51%3.47%
Quick Ratio3.60%0.81%3.12%1.08%2.60%
Ownership Information
Institutional Ownership Percentage92.17%N/A85.00%3.41%92.50%
Insider Ownership Percentage0.70%N/A11.84%N/A0.17%
Miscellaneous
Employees3,000100,6188,31447,49510,600
Shares Outstanding259.96 million3.73 billion107.13 million3.15 billion475.17 million
Next Earnings Date5/5/2021 (Estimated)N/A5/4/2021 (Estimated)5/12/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.